The British pharmaceutical giant GlaxoSmithKline said that some of its executives might have broken the law in China, the company’s strongest statement yet on a bribery and corruption scandal that has engulfed its China operations.
Glaxo says execs may have broken Chinese law
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.